View Single Post
Old 03-22-2016, 10:21 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,951
'Modest support' for PFS as OS surrogate in HER2-positive metastatic breast cancer

Progression-free survival only moderately correlates with overall survival at the individual and trial level in patients with HER2-positive metastatic breast cancer treated with HER2-targeted agents, say researchers.

More...
News is offline   Reply With Quote